BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03820986-completion@plaintrial.com
DTSTAMP:20261029T034838Z
DTSTART;VALUE=DATE:20241101
SUMMARY:Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With 
 Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advan
 ce Melanoma (MK-7902-003/E7080-G000-312/LEAP-003) — estimated completion
  date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03820986
URL:https://plaintrial.com/trial/NCT03820986
END:VEVENT
END:VCALENDAR